Leading research pharmacologist, expert in the clinical development of peptides and selective androgen receptor modulators (SARMs).
Dr. Monica Tatem is a recognized expert in the field of experimental endocrinology and pharmacotherapy. With over 10 years of experience in both academic and independent research laboratories, she focuses on studying the mechanisms of action of peptide compounds and SARMs, as well as their potential therapeutic applications for stimulating tissue regeneration, optimizing metabolism, and preserving muscle mass.
Explore the articles
A professional portrait of Dr. Monica Tatem in a modern research laboratory. She is shown wearing a dark blue business suit, with bookshelves containing medical and scientific literature in the background—a setting that underscores her expert status, academic approach, and extensive experience in the field of biomedical research.
Dr. Monica Tatem earned her Ph.D. in Molecular Pharmacology from a leading medical university, followed by postdoctoral research focused on anabolic pathways and cellular signaling.
Her scientific work encompasses a comprehensive analysis of the safety and efficacy of synthetic peptides and compounds known as SARMs (Selective Androgen Receptor Modulators). Dr. Tatem has led several clinical and preclinical studies aimed at evaluating the effects of these substances on bone and muscle tissue, specifically seeking to avoid the typical side effects associated with traditional anabolic steroids. She has authored numerous peer-reviewed publications in prominent international pharmacological journals and frequently presents her findings at specialized scientific congresses dedicated to innovations in sports medicine and endocrine therapy.
Three receptor targets make retatrutide a distinctive metabolic research molecule. Clinical evidence now includes phase 3 studies, with important differences between populations and outcomes.
Read the overviewTirzepatide connects GIP and GLP-1 receptor biology with a substantial clinical research programme. Understanding the molecule starts with separating its mechanism, study results and the identity of a finished medicine.
Read the overview
